Vitamin B12 deficiency with combined hematological and neuropsychiatric derangements: a case report

J Med Case Rep. 2014 Aug 15:8:277. doi: 10.1186/1752-1947-8-277.

Abstract

Introduction: Although vitamin B12 deficiency is a well-known cause of hematological and neuropsychiatric illness, the presentation of combined severe pancytopenia, demyelination and prominent psychiatric impairment is rare.

Case presentation: We present a case of a previously healthy 55-year-old East African man with severe vitamin B12 deficiency (serum vitamin B12 22pmol/L) secondary to pernicious anemia. He had a severe hypoproliferative megaloblastic anemia with hemolysis (hemoglobin 61g/L, mean corpuscular volume 99fL, reticulocytes 0.8%, haptoglobin undetectable), leukopenia (2.7×109/L), thrombocytopenia (96×109/L), ataxia with central demyelination, and megaloblastic madness. The patient's anemia, myelopathy and psychiatric condition responded well to parenteral vitamin B12 replacement therapy, with significant improvement seen within weeks.

Conclusion: Hematological manifestations of vitamin B12 deficiency are typically inversely correlated with the presence and severity of neuropsychiatric impairment. Although uncommon, a presentation with severe hematological and neuropsychiatric disease can occur, as illustrated by this case. Its presence may help guide diagnosis as well as provide clinically important prognostic information.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Megaloblastic / drug therapy
  • Anemia, Megaloblastic / etiology
  • Diagnosis, Differential
  • Diagnostic Imaging
  • Humans
  • Leukopenia / drug therapy
  • Leukopenia / etiology
  • Male
  • Mental Disorders / drug therapy
  • Mental Disorders / etiology
  • Middle Aged
  • Thrombocytopenia / drug therapy
  • Thrombocytopenia / etiology
  • Vitamin B 12 / therapeutic use*
  • Vitamin B 12 Deficiency / complications*
  • Vitamin B 12 Deficiency / diagnosis
  • Vitamin B 12 Deficiency / drug therapy

Substances

  • Vitamin B 12